Injection Mold Engineering · Stage-Gate Roadmap

Injection Mold Development Process: RFQ to Production

An injection mold project should advance through controlled gates. Each stage needs a defined input, decision, evidence, owner and exit condition before the next commitment begins.

What Are the Main Stages of Injection Mold Development?

A typical program moves from RFQ input review → DFM and risk closure → mold design freeze → steel release and mold build → static inspection and T0 readiness → trial and correction → validation and production release . Moldflow or other CAE is supporting evidence only when project risk requires additional analysis.

Core gate rule: completing an activity is not the same as passing a gate. The project advances only when required evidence is reviewed, blocking actions are closed or formally transferred, and the responsible owner approves the next commitment.

For quotation, tooling cost and lead-time context, use our mold cost, quote and lead-time decision guide . This page stays focused on the engineering route from project input to production release.

Page boundary: this guide owns sequence, gate decisions, evidence, ownership and handoff logic. Detailed DFM, Moldflow, mold-design, trial, inspection and validation methods remain in specialist guides.
Stage 1 · RFQ and Project Inputs

Confirm the RFQ Baseline Before DFM Starts

The first stage confirms that the project has enough controlled information for engineering review. It does not freeze the mold design; it freezes the input basis that DFM will evaluate.

Engineering review of injection mold RFQ project inputs before DFM
Stage 1 establishes the controlled project baseline used for the following DFM review.

A valid baseline normally includes the released CAD and drawing revision, material or resin basis, CTQs, cosmetic requirements, expected volume and tooling or export requirements. Conflicting revisions or assumptions should be resolved or listed as open items with an owner.

Stage Control

RFQ Input Baseline

Entry Condition Customer RFQ package received
Main Decision Are the inputs complete enough for DFM?
Evidence Controlled CAD, drawing, material and requirement baseline
Approval Owner Buyer / project engineer with supplier review
Exit Condition No missing input blocks meaningful DFM
Use the injection mold specification sheet to consolidate the agreed technical baseline before detailed tooling decisions begin.
Stage boundary: this stage does not perform DFM, select mold architecture or approve gates, cooling or ejection. Once the input baseline is controlled, the project moves to Stage 2 — DFM and Risk Review.
Stage 2 · DFM and Risk Review

Close Blocking Manufacturing Risks Before Mold Design Advances

Stage 2 determines whether the part definition is ready for detailed mold-design work. The goal is not to solve every tooling detail, but to prevent unresolved part-level risk from being carried into steel commitment.

Injection molding DFM risk review before mold design and tooling commitment
Stage 2 closes or assigns blocking manufacturing risks before detailed mold-design decisions advance.

Review risks that can materially change feasibility, mold architecture or downstream correction effort. These may include draft, wall transitions, undercuts, cosmetic exposure, tolerance-sensitive features, gating feasibility, ejection risk and cooling or warpage concerns.

When engineering review alone cannot close a flow, cooling or warpage question, Moldflow or other CAE evidence may be required.

Stage Control

DFM and Risk Review

Entry Condition Controlled RFQ baseline approved
Main Decision Are blocking manufacturing risks sufficiently dispositioned?
Evidence DFM risk record with actions, owners and closure status
Approval Owner Supplier engineering with customer engineering where required
Exit Condition No unresolved risk prevents mold-design progression
Risk disposition must be explicit: revise the part, define a tooling response, request further analysis, or formally accept the residual risk.
Stage boundary: this stage does not approve runner design, cooling layout, ejection layout, steel selection or trial parameters. Once blocking risks have an approved disposition, the project moves to Stage 3 — Mold Design Freeze.
Stage 3 · Mold Design Freeze

Freeze the Mold Design Before Irreversible Steel Work Begins

Stage 3 converts the approved DFM position into a controlled mold-design baseline. The goal is to confirm that the architecture is sufficiently defined and released before irreversible manufacturing begins.

Define the Architecture That Controls the Build

The approved package should capture the decisions that materially define the tool: mold layout, parting strategy, cavity and core definition, gate concept, cooling concept, ejection concept, steel selection, critical interfaces and the controlling revision.

Stage Control

Mold Design Freeze

Entry Condition Blocking DFM risks dispositioned
Main Decision Is the mold architecture ready for steel release?
Evidence Approved mold-design package and controlling revision
Approval Owner Tool designer, project engineer and customer where required
Exit Condition Design freeze and steel-release authorization issued
For deeper architecture decisions, use the injection mold design decision guide . This page only defines when the design is ready to advance.
Stage boundary: this stage does not teach runner sizing, cooling calculations, ejection design or component selection. Once design freeze is approved, the project moves to Stage 4 — Steel Release and Mold Build.
Stage 4 · Steel Release and Mold Build

Control the Mold Build Against the Approved Design Baseline

Stage 4 begins after design freeze and steel-release authorization. The objective is to keep manufacturing aligned with the approved revision, agreed milestones and evidence needed for assembly readiness.

Build to One Controlled Revision

Material release, machining, outsourced processes and component manufacture should follow the same design baseline. Any change affecting critical steel, interfaces or function should return through revision control before implementation.

Stage Control

Steel Release and Mold Build

Entry Condition Design freeze and steel-release authorization approved
Main Decision Is the tool progressing to the approved design and milestone plan?
Evidence Material records, milestone status, revision history and assembly-readiness evidence
Approval Owner Tooling project lead with engineering review
Exit Condition Build ready for static inspection and T0-readiness review
Track build timing and critical-path progress with the mold build milestone schedule .
Verify the records, release status and open actions required before each manufacturing stage advances with the manufacturing phase-gate checklist .
For supplier-managed tooling manufacture and export control, see export injection mold production .
Stage boundary: this stage does not teach CNC, EDM, grinding, heat treatment or electrode design. Once the controlled build is complete, the project moves to Stage 5 — Static Inspection and T0 Readiness.
Stage 5 · Static Inspection and T0 Readiness

Verify the Mold Before the First Molding Trial

Stage 5 separates build completion from trial readiness. The tool should enter T0 only after assembly, motion, utilities and critical interfaces are checked for safe first operation.

Precision injection mold static inspection before T0 trial readiness approval
Static inspection confirms that the completed mold is mechanically ready for its first molding trial.

Build Complete Does Not Mean T0 Ready

Static inspection confirms that the assembled tool is mechanically ready for molding evaluation. Evidence may include insert fit, slider or lifter movement, ejection function, cooling-circuit integrity, parting condition, visible damage and machine-interface readiness. The purpose is to prevent a static defect from becoming a trial failure or equipment risk.

Stage Control

Static Inspection and T0 Readiness

Entry Condition Controlled mold build completed
Main Decision Is the assembled tool safe and ready for the first molding trial?
Evidence Static inspection record, deviation status and pre-trial readiness evidence
Approval Owner Tooling engineering with toolmaking and quality support
Exit Condition Critical static issues closed and T0 mounting released
T0 release rule: manufacturing completion alone does not pass this stage. Blocking static risks must be closed and first-trial readiness approved.
Stage boundary: this stage does not evaluate filling, dimensions, cosmetics or process stability. Those questions begin in Stage 6 — T0, T1 and Correction.
Stage 6 · T0, T1 and Correction

Use Trial Evidence to Drive Correction and Verification

Stage 6 turns the first molding trial into a controlled correction loop. T0 establishes basic mold function and first molded evidence; later trials verify agreed corrections and determine whether the tool is ready to move toward validation.

Injection mold T0 first trial beginning the correction and verification cycle
T0 starts the evidence loop; later trials verify whether agreed mold corrections have produced the intended result.

At T0, the goal is to confirm that the mold can operate, fill sufficiently for engineering review and reveal major tooling issues. Findings should be recorded as mold correction, process adjustment, part revision or accepted residual risk—not simply as informal trial comments. Directional dimensional or cosmetic observations may be useful at T0, but they should not be mistaken for final acceptance evidence.

After meaningful corrections, T1 should verify whether the intended changes were effective and whether dimensional, cosmetic and functional evidence is stable enough for the next decision. An additional T2 or later trial is required only when important corrections or unresolved risks still need confirmation.

Trial Correction Loop
T0
→
Correction
→
T1 Verification
→
Additional Trial Only if Required
Stage Control

T0, T1 and Correction

Entry Condition T0 readiness approved
Main Decision Have trial findings been converted into verified corrective actions?
Evidence Trial record, sample set, issue list, measurement evidence and correction log
Approval Owner Tooling / molding engineering with project review
Exit Condition Major tooling corrections verified and remaining risks defined for validation
Correction-loop rule: the trial number is less important than evidence closure. Do not schedule another trial simply because “T2” is expected; run it when a meaningful correction or unresolved risk requires verification.
Stage boundary: this stage does not teach injection speed, holding pressure, barrel or mold temperature, V/P transfer, detailed FAI or process-window validation. Once major tooling corrections are verified, the project moves to Stage 7 — Validation and Production Release.
Stage 7 · Validation and Production Release

Confirm the Evidence Before Routine Production Is Approved

Stage 7 begins after major tooling corrections are verified. The purpose is to determine whether the tool, molded part and required evidence are complete enough for release—not simply whether the mold can make acceptable samples.

Move From Trial Success to Release Evidence

A successful trial is only one input to release. Evidence may include dimensional results, functional approval, cosmetic acceptance, a stable molding condition, required capability or customer documentation, and final tooling records. The package should follow the agreed validation scope.

Stage Control

Validation and Production Release

Entry Condition Major tooling corrections verified
Main Decision Is the tool, process and product evidence sufficient for production release?
Evidence Approved dimensional, functional, cosmetic and required process-validation records
Approval Owner Project engineering, quality and customer where required
Exit Condition Required evidence accepted and routine production release authorized
For detailed acceptance and evidence structure, use the injection mold validation guide . This page only defines when the project leaves the trial-and-correction phase.
Stage boundary: this stage does not teach FAI, CMM methodology, MSA, capability analysis, PPAP or process-window validation. It defines the evidence threshold for production release.
Stage-Gate Control Summary

Stage-Gate Owner and Evidence Summary

Use one release logic across the injection mold development program. This summary shows what must be ready, what decision is made, what evidence is retained, who approves it and what allows the project to advance. It is a project-control view, not a replacement for detailed engineering methods.

Stage Entry Condition Main Decision Evidence Approval Owner Exit Condition
Stage 1
RFQ Inputs 		RFQ package received Inputs complete enough for engineering review? Controlled CAD, drawing, material and requirements Buyer / project engineer Ready for DFM
Stage 2
DFM & Risk 		Controlled RFQ baseline Blocking manufacturing risks dispositioned? DFM risk record with actions and owners Supplier engineering / customer engineering as required Ready for mold design
Stage 3
Design Freeze 		Blocking DFM risks closed Architecture ready for steel release? Approved design package and revision Tool designer / project engineer Steel release authorized
Stage 4
Mold Build 		Design freeze approved Build aligned with approved baseline? Material, milestone and revision records Tooling project lead Ready for static inspection
Stage 5
T0 Readiness 		Controlled build complete Tool safe for first trial? Static inspection and readiness record Tooling engineering T0 released
Stage 6
Trial & Correction 		T0 readiness approved Corrective actions verified? Trial records, samples and correction log Tooling / molding engineering Major corrections verified
Stage 7
Validation & Production Release 		Major corrections verified Release evidence sufficient? Dimensional, functional, cosmetic and required validation records Project engineering / quality / customer as required Production release authorized

On smaller screens, swipe horizontally to review the complete stage-gate table.

Control principle: a stage passes only when required evidence exists, blocking actions are closed or formally transferred, and the responsible owner approves the next commitment.
Injection Mold Development FAQ

Common Questions Before Production Release

These answers summarize the stage-gate roadmap without repeating the specialist methods covered earlier.

What are the main stages of injection mold development?

A controlled program moves through RFQ inputs, DFM and risk review, mold design freeze, mold build, static inspection and T0 readiness, trial and correction, then validation and production release.

How long does injection mold development take?

Timing depends on part complexity, design closure, build scope, correction cycles and required validation evidence. Control the program against approved milestones rather than one generic duration.

Is Moldflow required for every mold?

No. Moldflow or other CAE is supporting evidence when flow, cooling or warpage risk cannot be closed confidently through engineering review alone.

What is the difference between T0 and T1?

T0 checks basic mold function and first molded evidence. After correction, T1 verifies whether the intended changes worked. Additional trials are used only when important risks still need confirmation.

When is a mold ready for production release?

Release requires more than acceptable samples. Required dimensional, functional, cosmetic, process and customer evidence must be complete, blocking actions closed or accepted, and the responsible team must approve release.

Final Project Handoff

Need an Engineering Review Before Tooling Commitment?

Send your part data, material, volume and key requirements. We can review the current stage, open risks and evidence needed before the next commitment.

Submit Your Project for Engineering Review